Global Defibrillators Market Projected to Reach USD 11.7 Billion by 2025
|
By HospiMedica International staff writers Posted on 17 Mar 2020 |
|
Image: Attractive opportunities in the global defibrillators market (Photo courtesy of MarketsandMarkets)
The global defibrillators market is projected to grow at a CAGR of 3.4% from USD 9.6 billion in 2019 to USD 11.7 billion by 2025, driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. Additionally, the emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for the players in the defibrillators market. However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and lack of awareness about sudden cardiac arrest in the developing countries are expected to hinder the growth of the market during the forecast period.
These are the latest findings of MarketsandMarkets (Maharashtra, India), a market research and management consulting firm.
On the basis of type, the implantable cardioverter defibrillators (ICDs) segment held the largest share in the global defibrillators market in 2019. This was due to the development of technologically-advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and S-ICD systems across the world.
On the basis of end users, the hospitals, clinics, and cardiac centers segment accounted for the largest share of the global defibrillators market in 2019 due to the growing number of cardiac implant procedures and availability of reimbursements across the developed markets.
Geographically, North America accounted for the largest share of the global defibrillators market in 2019 due to the rising geriatric population, increasing incidence of cardiac diseases, and technological advancements in the region. Increasing efforts by governments in the region to provide the necessary care to cardiac arrest victims at public places through public-access defibrillation programs have also increased the demand for defibrillators in North America.
Related Links:
MarketsandMarkets
.jpg)
These are the latest findings of MarketsandMarkets (Maharashtra, India), a market research and management consulting firm.
On the basis of type, the implantable cardioverter defibrillators (ICDs) segment held the largest share in the global defibrillators market in 2019. This was due to the development of technologically-advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and S-ICD systems across the world.
On the basis of end users, the hospitals, clinics, and cardiac centers segment accounted for the largest share of the global defibrillators market in 2019 due to the growing number of cardiac implant procedures and availability of reimbursements across the developed markets.
Geographically, North America accounted for the largest share of the global defibrillators market in 2019 due to the rising geriatric population, increasing incidence of cardiac diseases, and technological advancements in the region. Increasing efforts by governments in the region to provide the necessary care to cardiac arrest victims at public places through public-access defibrillation programs have also increased the demand for defibrillators in North America.
Related Links:
MarketsandMarkets
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Half Apron
Demi
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Latest Business News
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- Boston Scientific Acquires Medical Device Company SoniVie
- 2026 World Hospital Congress to be Held in Seoul
- Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
- Philips and Mass General Brigham Collaborate on Improving Patient Care with Live AI-Powered Insights
- Arab Health 2025 Celebrates Landmark 50th Edition
- Boston Scientific Acquires Medical Device Company Intera Oncology
- MEDICA 2024 to Highlight Hot Topics of MedTech Industry
- Start-Ups To Once Again Play Starring Role at MEDICA 2024
- Boston Scientific to Acquire AFib Ablation Company Cortex
Channels
Critical Care
view channel
AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
For decades, doctors have relied on standardized scoring systems to assess patients with the most common type of heart attack—non-ST-elevation acute coronary syndrome (NSTE-ACS). The GRACE score, used... Read more
'Universal' Kidney to Match Any Blood Type
Blood-type incompatibility has long been one of the greatest obstacles in organ transplantation, forcing thousands of patients—particularly those with type O blood—to wait years longer for compatible donors.... Read more
Surgical Techniques
view channel
Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read more
Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
